Condition: T3c Diabetes · Sponsor: Zhejiang University
The purpose of this clinical trial is to verify the safety and effectiveness of autologous islet organoids transplantation after in vitro expansion for the treatment of pancreatogenic diabetes.
This description comes directly from the study's public registry record.
Xi Ma, MD · 86-18768117002 · xima@zju.edu.cn
Qing Cissy Yu, PhD · 86-13916205952 · qing.yu@newislet.com
Always discuss trial participation with your own doctor first.
| Zhejiang University Second Affiliated Hospital | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06415643